Perrigo to Separate its Prescription Pharmaceutical Business
Shots:
- Perrigo’s separated business helps it to lead the main focus on consumer business- which includes generic medicines including topical creams- foams- mousses- gels- liquids and inhalable products
- It may include a tax-efficient separation to shareholders- a sale or merger with no assurance as to form and timing of transaction
- This separation of business is expected to complete during H2’19
Ref: Perrigo | Image: Honey Creative
Click here to read the full press release
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com